Progression to Dementia in Very Late‐Onset Schizophrenia‐Like Psychosis Stratified by A lzheimer's Disease and L ewy Body Disease Biomarkers: A Retrospective Cohort Study
Open Access
- 10 August 2026
- journal article
- Published by Wiley in Psychogeriatrics
- Vol. 26 (5) , e70205
Abstract
Background: Very late‐onset schizophrenia‐like psychosis (VLOSLP) is clinically heterogeneous, and its relationship with dementia‐related neurodegenerative disease remains unresolved. We examined whether Alzheimer's disease (AD) and Lewy body disease (LBD) biomarker status were associated with dementia progression in VLOSLP. Methods: We retrospectively identified patients who visited the University of Osaka Hospital between January 2018 and December 2023 and met criteria for VLOSLP. Twenty‐two participants with AD and/or LBD biomarker data and at least one follow‐up assessment within 775 days were classified as biomarker‐negative (BMs‐neg; n = 7) or biomarker‐positive (BMs‐pos; n = 15). Group comparisons were performed using Mann–Whitney U tests and Fisher's exact tests. Results: The BMs‐pos group showed older onset age and lower memory scores than the BMs‐neg group. Dementia progression was more frequent in the BMs‐pos group than in the BMs‐neg group, although the difference was not statistically significant (8/15 [53.3%] vs. 1/7 [14.3%]; p = 0.165; odds ratio 6.31; 95% CI 0.55–353.18). Five of eight participants with AD biomarker positivity progressed to AD dementia. Three of seven participants with LBD biomarker positivity progressed to dementia, including two diagnosed with dementia with Lewy bodies. Follow‐up MMSE, CDR, and CDR‐SB scores differed significantly between groups. Conclusions: AD and/or LBD biomarker‐positive VLOSLP may be associated with greater dementia progression and cognitive decline, although findings should be interpreted cautiously given the small sample size and retrospective design. These results support the clinical value of considering neurodegenerative biomarkers when evaluating the prognosis and underlying pathology of VLOSLP.Keywords
All Related Versions
Funding Information
- Japan Society for the Promotion of Science (TK21K15730)
- SENSHIN Medical Research Foundation (Overseas Study grant)
This publication has 46 references indexed in Scilit:
- Complex cases with suspected dementia in the community need psychiatric support: Results from a nationwide survey in JapanAsian Journal of Psychiatry, 2023
- Risk of dementia and death in very-late-onset schizophrenia-like psychosis: A national cohort studySchizophrenia Research, 2020
- Mild cognitive impairment with Lewy bodies: neuropsychiatric supportive symptoms and cognitive profilePsychological Medicine, 2020
- Neuropsychiatric symptoms and cognitive profile in mild cognitive impairment with Lewy bodiesPsychological Medicine, 2018
- 123I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography and 123I‐metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative studyAnnals of Neurology, 2016
- Prodromal dementia with Lewy bodiesPsychological Medicine, 2014
- The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 2011
- Late and very‐late first‐contact schizophrenia and the risk of dementia–a nationwide register based studyInternational Journal of Geriatric Psychiatry, 2008
- Psychosocial correlates of late-onset psychosis: life experiences, cognitive schemas, and attitudes to ageingInternational Journal of Geriatric Psychiatry, 2004
- Phenomenology, demography and diagnosis in late paraphreniaPsychological Medicine, 1994